Mammary Gland

Introduction

Introduction to the Mammary Gland

The mammary gland is a specialized exocrine gland in the female reproductive system responsible for milk production (lactation). It undergoes significant structural and functional changes under hormonal influence, particularly during puberty, pregnancy, and lactation. The gland consists of a system of ducts and secretory alveoli embedded in connective and adipose tissue, organized into lobes and lobules.

Developmental and Functional Overview

Mammary gland development begins in utero but remains rudimentary until puberty, when estrogen and progesterone stimulate ductal elongation and branching. During pregnancy, prolactin and placental lactogen promote alveolar differentiation and milk synthesis. Post-lactation, the gland undergoes involution, reverting to a resting state. Understanding its histology is critical for recognizing normal and pathological changes.

Study

Structural Organization of the Mammary Gland

The mammary gland is composed of 15–20 lobes, each drained by a lactiferous duct that opens at the nipple. Lobes are subdivided into lobules, which contain clusters of alveoli (acini) lined by secretory epithelial cells. The stroma consists of loose connective tissue, adipose tissue, and a rich vascular and lymphatic network. The terminal duct lobular unit (TDLU) is the functional and pathological unit of the gland, where most proliferative changes occur.

Histology of the Resting Mammary Gland

In the non-pregnant, non-lactating state, the mammary gland is predominantly composed of dense connective tissue with sparse ductal structures. The ducts are lined by a bilayered epithelium: an inner layer of cuboidal or low columnar epithelial cells and an outer layer of myoepithelial cells. Myoepithelial cells contain contractile proteins (e.g., actin) and play a role in milk ejection during lactation. The stroma is collagen-rich and contains scattered lymphocytes and plasma cells.

Changes During Pregnancy and Lactation

During pregnancy, the mammary gland undergoes lobuloalveolar development under the influence of estrogen, progesterone, prolactin, and human placental lactogen. Alveoli proliferate and differentiate into milk-secreting units, while the stroma becomes less prominent. Lactation is characterized by fully developed alveoli lined by tall columnar epithelial cells with apical lipid droplets and protein-rich secretions. Myoepithelial cells contract in response to oxytocin, facilitating milk ejection.

Involution and Post-Lactational Regression

After weaning, the mammary gland undergoes involution, a process of programmed cell death and tissue remodeling. Alveoli collapse, and epithelial cells undergo apoptosis, while the stroma regains its prominence. Macrophages and other immune cells clear cellular debris, and the gland returns to a resting state. Incomplete involution may contribute to pathological conditions such as fibrocystic changes or neoplasia.

Blood Supply, Lymphatics, and Innervation

The mammary gland receives arterial blood from branches of the internal thoracic, lateral thoracic, and intercostal arteries. Venous drainage follows the arterial supply. Lymphatic drainage is primarily to the axillary lymph nodes, with some drainage to the internal mammary chain. Innervation is provided by intercostal nerves, which carry sensory fibers to the nipple and areola, playing a role in the suckling reflex and milk ejection.

Summary

Key Takeaways

The mammary gland is a dynamic organ that undergoes cyclic changes under hormonal control. Its structure includes lobes, lobules, ducts, and alveoli, with a bilayered epithelium of secretory and myoepithelial cells. Development, lactation, and involution are tightly regulated processes, and disruptions can lead to pathological conditions such as mastitis, fibrocystic disease, or carcinoma.

Clinical Correlate: Pathological Changes

Histological examination of the mammary gland is essential for diagnosing breast diseases. For example, ductal carcinoma in situ (DCIS) arises from the epithelial cells of the TDLU, while lobular carcinoma originates in the lobules. Fibrocystic changes, such as cysts and fibrosis, are common benign conditions that must be distinguished from malignancy. Understanding normal histology aids in identifying early pathological alterations.

Hormonal Regulation and Therapeutic Implications

Hormonal therapies, such as estrogen receptor modulators (e.g., tamoxifen) or aromatase inhibitors, are used in the treatment of hormone-sensitive breast cancers. These therapies target the same hormonal pathways that regulate normal mammary gland development and function. Knowledge of mammary gland histology is crucial for understanding the mechanisms of these treatments and their effects on breast tissue.